09/07/2026 - Campus Can Ruti, Projects, Research

BST and IGTP are advancing the use of the particles that cells use to communicate as revolutionary therapies for the future

Researchers from BST, IGTP and Biosfer Teslab have demonstrated the potential of Nuclear Magnetic Resonance to monitor and optimise the manufacture of extracellular vesicles, one of the most promising therapeutic platforms in regenerative medicine. The findings, published in the Journal of Extracellular Vesicles, could help facilitate the development and scale-up of these therapies.

20/05/2026 - Research

Cardiac organoids show potential for myocardial repair after infarction

In a study recently published in the journal Theranostics, a research team led by Dr Carolina Gálvez-Montón (IGTP- Heart Failure and Cardiac Regeneration -ICREC group) and Dr Kurt Pfannkuche (University of Cologne) reports the development of a strategy based on cardiac organoids to address these limitations.

15/05/2026 - Campus Can Ruti, Institutional, PATH, Success Stories

IGTP launches the PATH program to strengthen advanced therapies at the Can Ruti Campus

IGTP has presented the PATH Advanced Therapies Program (Program of Advanced Therapies) at an event held on 14 May in the auditorium of Hospital Germans Trias i Pujol.

19/03/2026 - Campus Can Ruti, Innovation

Banc de Sang i Teixits hosts an Innomed meeting to share capabilities in advanced therapies

The Innomed community visited the Banc de Sang i Teixits (BST) yesterday as part of a new meeting organised within the framework of the Innomed programme, led by the Germans Trias i Pujol Research Institute (IGTP), with the aim of strengthening connections between research institutions, hospitals and organisations within the biomedical ecosystem, and exploring new opportunities for collaboration in the field of advanced therapies and health innovation.

13/03/2026 - Campus Can Ruti, Outreach, Success Stories

IGTP and Germans Trias Hospital join forces on the podcast Un bri de ciència, launching a new episode on myocardial infarction

As part of the European Day for the Prevention of Cardiovascular Risk, the podcast launches its eleventh episode, dedicated to myocardial infarction, featuring Ferran Rueda and Santi Roura from Germans Trias i Pujol Hospital and Research Institute, respectively.

10/03/2026 - Campus Can Ruti, Conferences, Innovation, Projects

IGTP takes part in the innovation ecosystem of the Mobile World Congress 2026

IGTP took part in the 2026 edition of MWC and 4YFN with professionals and spin-offs from the institute, showcasing projects in health innovation and strengthening its role in connecting biomedical research with companies, investors and institutions to advance technologies with potential clinical and societal impact.

09/02/2026 - Research

A study links the protein HDAC11 as a key factor in muscle deterioration in Duchenne muscular dystrophy

A preclinical study led by IGTP, in collaboration with the Institut de Myologie and the IR Sant Pau, has analysed the role of the protein HDAC11 in Duchenne muscular dystrophy and its potential as a therapeutic target. The results of the study have been published in the journal Life Sciences.

04/09/2025 - Campus Can Ruti, Projects, Research, Success Stories

Germans Trias, the first centre in Spain to include a patient in an international study on the early treatment of aortic stenosis

The iCor team at the Germans Trias i Pujol University Hospital and Research Institute is the first in Spain to enrol a patient in the international EASY-AS study, a clinical trial to evaluate whether intervening before the first symptoms of severe aortic stenosis appear can improve clinical outcomes.

17/07/2025 - Campus Can Ruti, Research

New insights into heart scar tissue could improve treatment after heart attacks

A team of researchers from the IGTP has taken a step forward in understanding the complex structure of heart scars that form after a myocardial infarction. Using a porcine model, the group found an association between specific electrical patterns and structural characteristics of the scar, offering a new approach that may guide more targeted and effective treatments for arrhythmias. The results have been published in the journal Heart Rhythm.

30/06/2025 - Innovation, Institutional, Projects, Success Stories

Boehringer Ingelheim and the Germans Trias i Pujol Research Institute strengthen their collaboration in preclinical research

The agreement between Boehringer Ingelheim and IGTP builds on a collaboration that began in 2020 to improve understanding of cardio-renal-metabolic diseases and their interconnection, and now includes the development of a new line of research to assess the potential of novel molecules in this field.